Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

BRCA1 mutation + BRCA2 mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

BRCA1 mutation + BRCA2 mutation	Pancreatic Ductal Adenocarcinoma	BRCA1 mutation + BRCA2 mutation	Pancreatic Ductal Adenocarcinoma	FOLFIRINOX Sensitive: C3 – Early Trials FOLFIRINOX Sensitive : C3	FOLFIRINOX Sensitive: C3 – Early Trials FOLFIRINOX Sensitive : C3
BRCA1 mutation + BRCA2 mutation	Breast Cancer	BRCA1 mutation + BRCA2 mutation	Breast Cancer	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3
BRCA1 mutation + BRCA2 mutation	Ovarian Cancer	BRCA1 mutation + BRCA2 mutation	Ovarian Cancer	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3	fluzoparib Sensitive: C3 – Early Trials fluzoparib Sensitive : C3
BRCA1 mutation + BRCA2 mutation	Prostate Cancer	BRCA1 mutation + BRCA2 mutation	Prostate Cancer	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3	GnRH stimulant Resistant: C3 – Early Trials GnRH stimulant Resistant : C3